NDC 63868-732

Nicotine Polacrilex Lozenge Mint

Nicotine Polacrilex Lozenge 4 Mg

Nicotine Polacrilex Lozenge Mint is a Oral Lozenge in the Human Otc Drug category. It is labeled and distributed by Chain Drug Marketing Association Inc. The primary component is Nicotine.

Product ID63868-732_e7def4df-9fe4-ce48-c016-09ff448c40f5
NDC63868-732
Product TypeHuman Otc Drug
Proprietary NameNicotine Polacrilex Lozenge Mint
Generic NameNicotine Polacrilex Lozenge 4 Mg
Dosage FormLozenge
Route of AdministrationORAL
Marketing Start Date2021-04-01
Marketing CategoryANDA /
Application NumberANDA212796
Labeler NameChain Drug Marketing Association INC
Substance NameNICOTINE
Active Ingredient Strength4 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63868-732-24

1 BOTTLE in 1 CARTON (63868-732-24) > 24 LOZENGE in 1 BOTTLE
Marketing Start Date2021-04-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Nicotine Polacrilex Lozenge Mint" or generic name "Nicotine Polacrilex Lozenge 4 Mg"

NDCBrand NameGeneric Name
63868-732Nicotine Polacrilex Lozenge MintNicotine Polacrilex Lozenge 4 mg
63868-733Nicotine Polacrilex Lozenge MintNicotine Polacrilex Lozenge 2 mg
43598-987HabitrolNicotine Polacrilex Lozenge 4 mg

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.